MBX
MBX Biosciences, Inc.
Latest Form 4:Sale$24KbyAzoulay Salomon (Chief Medical Officer) · filed Aug 5, 2026
MBX Biosciences, Inc. (MBX) has 16 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 5, 2026.
The most active filer is Chief Medical Officer Azoulay Salomon with 3 filings. Insiders have net sold $2.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Peter Kent Hawryluk
- Employees:43
- HQ:Carmel, IN, US
- IPO:2000-01-14
Insider Buying
$13.1M
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$3.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 370 | $24K | Aug 5 | SEC ↗ | |
| Chief Medical Officer | Sale | 70,003 | $2.7M | May 11 | SEC ↗ | |
| President & CEO | Sale | 607 | $18K | May 8 | SEC ↗ | |
Azoulay SalomonFirst filing | Chief Medical Officer | Sale | 231 | $7K | May 8 | SEC ↗ |
Hawryluk P. KentFirst in 5 months | President & CEO | Purchase | 18,500 | $526K | Mar 16 | SEC ↗ |
Hawryluk P. KentFirst filing | President & CEO | Purchase | 20,000 | $273K | Oct 21 | SEC ↗ |
Hoerter Steven L.First filing | Director | Purchase | 20,000 | $265K | Oct 20 | SEC ↗ |
Heron Patrick JFirst filing | Director, 10% Owner | Purchase | 666,666 | $12.0M | Sep 30 | SEC ↗ |
Related companies
MBX Biosciences, Inc. is in the Healthcare sector.